FDA Drug information
Vigabatrin
Up to date, easily accessible information about drugs approved by the US Food & Drug Administration (FDA)
- Vigabatrin VIGABATRIN 50 mg/mL Actavis Pharma, Inc.
- VIGABATRIN VIGABATRIN 50 mg/mL Ascend Laboratories, LLC
- Vigabatrin VIGABATRIN 50 mg/mL Novadoz Pharmaceuticals LLC
- VIGABATRIN VIGABATRIN 50 mg/mL Par Pharmaceutical, Inc.
- Vigabatrin VIGABATRIN 500 mg/1 Amneal Pharmaceuticals NY LLC
- Vigabatrin VIGABATRIN 500 mg/1 Aurobindo Pharma Limited
- Vigabatrin VIGABATRIN 500 mg/1 Aurobindo Pharma Limited
- Vigabatrin VIGABATRIN 500 mg/1 Cadila Healthcare Limited
- Vigabatrin VIGABATRIN 500 mg/1 Zydus Pharmaceuticals (USA) Inc.
- VIGABATRIN VIGABATRIN 500 mg/mL Cipla USA, Inc.
Learning Zones
Disclaimer
The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).
Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.
Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.